Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Net Margin (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Net Margin for 15 consecutive years, with 7.89% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 741.0% to 7.89% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 5.65% through Dec 2025, up 1056.0% year-over-year, with the annual reading at 5.65% for FY2025, 1056.0% up from the prior year.
  • Net Margin hit 7.89% in Q4 2025 for Cumberland Pharmaceuticals, up from 23.5% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 10.66% in Q1 2025 to a low of 67.38% in Q4 2023.
  • Historically, Net Margin has averaged 8.51% across 4 years, with a median of 7.34% in 2025.
  • Biggest YoY gain for Net Margin was 5208bps in 2024; the steepest drop was -2426bps in 2024.
  • Year by year, Net Margin stood at 6.05% in 2021, then plummeted by -1214bps to 67.38% in 2023, then skyrocketed by 77bps to 15.3% in 2024, then soared by 48bps to 7.89% in 2025.
  • Business Quant data shows Net Margin for CPIX at 7.89% in Q4 2025, 23.5% in Q3 2025, and 6.78% in Q2 2025.